Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11405115rdf:typepubmed:Citationlld:pubmed
pubmed-article:11405115lifeskim:mentionsumls-concept:C0015624lld:lifeskim
pubmed-article:11405115lifeskim:mentionsumls-concept:C0013081lld:lifeskim
pubmed-article:11405115lifeskim:mentionsumls-concept:C1517004lld:lifeskim
pubmed-article:11405115pubmed:issue5lld:pubmed
pubmed-article:11405115pubmed:dateCreated2001-6-14lld:pubmed
pubmed-article:11405115pubmed:abstractTextThe pathogenesis of renal phosphate (Pi) leak in Fanconi syndrome is unknown. Disorders of apical membrane transporters, leaky apical membrane, depleted cellular Pi and ATP, and impaired sodium (Na) pumps have been proposed as underlying defects. The present study examined the role of type II Na-Pi cotransport system (NaPi-2) in experimental Fanconi syndrome in rats. Following a single injection of maleic acid (MA), 75 mg/kg body weight i.p., rats were sacrificed after 90 min, 4 h, and 24 h. Renal cortical expression of NaPi-2 mRNA was determined by Northern blotting, and brush border membrane (BBM) NaPi-2 protein by Western blotting. Increased urinary excretion of phosphate was demonstrated as soon as 90 min after MA injection, and was sustained at 4 and 24 h, NaPi-2 mRNA expression and NaPi-2 protein were not decreased after 90 min. NaPi-2 mRNA decreased after 4 h, while NaPi-2 protein decreased only at 24 h. Hence, the immediate phosphaturia in experimental Fanconi syndrome may be independent of NaPi-2 downregulation, possibly resulting from energy depletion or membrane dysfunction. The decrease in NaPi-2 mRNA expression and the subsequent NaPi-2 protein decrease may account for the second-phase phosphaturia.lld:pubmed
pubmed-article:11405115pubmed:languageenglld:pubmed
pubmed-article:11405115pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11405115pubmed:citationSubsetIMlld:pubmed
pubmed-article:11405115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11405115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11405115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11405115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11405115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11405115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11405115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11405115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11405115pubmed:statusMEDLINElld:pubmed
pubmed-article:11405115pubmed:monthMaylld:pubmed
pubmed-article:11405115pubmed:issn0931-041Xlld:pubmed
pubmed-article:11405115pubmed:authorpubmed-author:LeviMMlld:pubmed
pubmed-article:11405115pubmed:authorpubmed-author:WaldHHlld:pubmed
pubmed-article:11405115pubmed:authorpubmed-author:PopovtzerM...lld:pubmed
pubmed-article:11405115pubmed:authorpubmed-author:Dranitzki-Elh...lld:pubmed
pubmed-article:11405115pubmed:authorpubmed-author:HavivY SYSlld:pubmed
pubmed-article:11405115pubmed:issnTypePrintlld:pubmed
pubmed-article:11405115pubmed:volume16lld:pubmed
pubmed-article:11405115pubmed:ownerNLMlld:pubmed
pubmed-article:11405115pubmed:authorsCompleteYlld:pubmed
pubmed-article:11405115pubmed:pagination412-6lld:pubmed
pubmed-article:11405115pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:meshHeadingpubmed-meshheading:11405115...lld:pubmed
pubmed-article:11405115pubmed:year2001lld:pubmed
pubmed-article:11405115pubmed:articleTitleLate-onset downregulation of NaPi-2 in experimental Fanconi syndrome.lld:pubmed
pubmed-article:11405115pubmed:affiliationNephrology and Hypertension Services, Hadassah-Hebrew University Medical Center, POB 12000, Jerusalem, Israel 91120.lld:pubmed
pubmed-article:11405115pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11405115pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:11405115pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed